Cargando…
Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101758/ https://www.ncbi.nlm.nih.gov/pubmed/37062303 http://dx.doi.org/10.1016/S1473-3099(23)00187-1 |
| _version_ | 1785025575864238080 |
|---|---|
| author | Stoliaroff-Pepin, Anna Harder, Thomas |
| author_facet | Stoliaroff-Pepin, Anna Harder, Thomas |
| author_sort | Stoliaroff-Pepin, Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10101758 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101017582023-04-14 Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations Stoliaroff-Pepin, Anna Harder, Thomas Lancet Infect Dis Comment Elsevier Ltd. 2023-04-14 /pmc/articles/PMC10101758/ /pubmed/37062303 http://dx.doi.org/10.1016/S1473-3099(23)00187-1 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Stoliaroff-Pepin, Anna Harder, Thomas Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations |
| title | Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations |
| title_full | Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations |
| title_fullStr | Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations |
| title_full_unstemmed | Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations |
| title_short | Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations |
| title_sort | effectiveness of bivalent mrna booster vaccines against covid-19: methodological and public health considerations |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101758/ https://www.ncbi.nlm.nih.gov/pubmed/37062303 http://dx.doi.org/10.1016/S1473-3099(23)00187-1 |
| work_keys_str_mv | AT stoliaroffpepinanna effectivenessofbivalentmrnaboostervaccinesagainstcovid19methodologicalandpublichealthconsiderations AT harderthomas effectivenessofbivalentmrnaboostervaccinesagainstcovid19methodologicalandpublichealthconsiderations |